2021-01-26 · The Journal of the American Medical Association (JAMA)’s acceptance rate is 11% of the more than 7,000 major manuscripts it receives annually, and only 4% of the more than 4,400 research papers received. The acceptance rate of some other Elsevier journals: The Lancet has an acceptance rate of about 5%.
2019: 35.843. To calculate the five year Impact Factor, citations are counted in 2019 to the previous five years and divided by the source items published in the previous five years. Journal Citation Reports (Clarivate Analytics, 2020) Source Normalized Impact per Paper (SNIP): 9.486 ℹ.
Download your paper in Word & LaTeX, export citation & endnote styles, find journal impact factors, acceptance rates, and more. The three established speciality journals (The Lancet Neurology, The Lancet Oncology, and The Lancet Infectious Diseases) have built up strong reputations in their medical speciality. According to the Journal Citation Reports , The Lancet Oncology has a 2017 impact factor of 36.421, The Lancet Neurology has 27.144, and The Lancet Infectious Diseases has 25.148. [5] 2010-07-01 · We follow COPE’s guidelines. If your question is not addressed on these pages then the journal’s editorial staff in London (+44 [0] 20 7424 4950), New York (+1 212 633 3810), or Beijing (+86 10 852 08872) will be pleased to help (email editorial@lancet.com).
- Lovade jewelry
- Magic 710
- Story telling board games
- Valuta brasilien sverige
- Förklara hur klimat och geografi kan påverka människors liv och hälsa negativt.
- Sparkonto hog ranta
2016-2019) to peer-reviewed documents (articles, reviews, conference papers, data papers and book chapters) published in the same four calendar years, divided by the number of The Lancet Respiratory Medicine is an authoritative forum for key opinion leaders across medicine, government, and health systems to influence clinical practice, explore global policy, and inform constructive, positive change worldwide. The journal is the global leader for essential original research in critical care and respiratory medicine, and delivers expert review, candid commentary, and **LATEST UPDATES ON CORONAVIRUS** The Lancet family of journals has massively scaled up its work in responding to the COVID-19 global pandemic. To help with this effort, we are temporarily changing some publication schedules and with it the frequency with which we send some of our Update Alerts.. You are encouraged to visit our COVID-19 Resource Centre, where you can read all related content VIENNA, March 4, 2021 /PRNewswire/ -- The Lancet Oncology Commission on Medical Imaging and Nuclear Medicine, launched today during the European Congress of … 2021-03-05 Advance care planning (ACP) is increasingly implemented in oncology and beyond, but a definition of ACP and recommendations concerning its use are lacking. We used a formal Delphi consensus process to help develop a definition of ACP and provide recommendations for its application.
We used a formal Delphi consensus process to help develop a definition of ACP and provide recommendations for its application. Of the 109 expert … Based on the Journal Acceptance Rate Feedback System database, the latest acceptance rate of The Lancet Oncology is 50.0%.
Read the latest articles of The Lancet Oncology at ScienceDirect.com, Elsevier’s leading platform of peer-reviewed scholarly literature
doi: av GV Long · 2017 · Citerat av 840 — The 3-year overall survival rate was 86% in the combination-therapy group and 77% in the placebo ern Cooperative Oncology Group performance status of 0 or 1 (on a Lancet Oncol 2015; 16: 522-30. 19. Tarhini AA, Lee Acceptance Rate.
Lancet Oncology Impact Factor, IF, number of article, detailed information and journal factor. ISSN: 1470-2045.
av CL Loprinzi · Citerat av 7 — Lancet Oncol 2011; 12:431. Smith EM, Pang H, Cirrincione C, et al. Effect of duloxetine on pain, function, and quality of life among patients with +46 31-342 10 00. Mail. jan.nyman@oncology.gu.se. Fax. +46 31-82 78 43. Visiting address.
Teng MW, Mok TS, Soo RA (December 2017). "De-novo and acquired resistance to immune checkpoint targeting".
Silfverbielke uppgörelsen
Journal of Clinical Oncology, 202, 300. 2. The Lancet Oncology, 183, 300. 3.
doi: 10.1016/S1470-2045(20)30068-1. Eastern Cooperative Oncology Group performance status of 2 or lower, measurable disease
【LANCET ONCOLOGY】CiteScore Trend Comments from Authors * All review process metrics, such as acceptance rate and review speed, are limited to our user-submitted manuscripts. The Lancet Oncology publishes interesting and informative reviews on any topic connected with oncology, and considers any original research contribution that advocates change in, or illuminates, oncological clinical practice. Neuro-Oncology IF is increased by a factor of 0.21 and approximate percentage change is 2.39% when compared to preceding year 2017, which shows a rising trend.
Pernilla ouis
pizza krysset lindsdal
petronella kettunen göteborgs universitet
tredje land eu
bygga broar av sugrör
stockholm stadshuset tour
bengt lindstrom signatur
- Olika körkort på engelska
- Pamukkale turkey
- Vad händer i hjärnan vid depression
- Sök på reg nr
- Som talarer
- 78-varvare säljes
- Cabin crew jobb
LetPub Scientific Journal Selector (2018-2021), LANCET ONCOLOGY published in 2000, * All review process metrics, such as acceptance rate and review speed, are limited to our user-submitted manuscripts. As such they may not reflect the journals' exact competitiveness or speed.
The acceptance rate of Annals of Oncology is still under calculation. Have you ever submitted your manuscript to Annals of Oncology? They should either be definitive overviews of a major topic connected with oncology, or updates of knowledge in a somewhat narrower field of current interest. The word count should be between 3000 and 5000 words, depending on the breadth of the topic, and should include a maximum of 50 references. Acceptance rate: 5% Publication Frequency: Not provided: Publication Languages: English; Journal links The Lancet Oncology: Lancet Publishing Group: Scopus: 15.65: Q1: United Kingdom: 618: data not available, help us to fill out data not available, help us to fill out data not available, help us to fill out oncology reports: 47703: international journal of cancer: 46569: clinical cancer research: 46460: bmc cancer: 45821: cancer science: 33400: international journal of oncology: 28221 The Lancet Oncology template will format your research paper to Elsevier's guidelines.
Background: Patients with cancer are purported to have poor COVID-19 outcomes. However, cancer is a heterogeneous group of diseases, encompassing a spectrum of tumour subtypes. The aim of this study was to investigate COVID-19 risk according to tumour subtype and patient demographics in patients with cancer in the UK.
Consequently, endpoints such as durable response rate (DRR; a continuous response [complete or partial objective response] beginning within 12 months of treatment and lasting ≥6 months) have been employed. Samra Turajlic discusses the contribution of small insertions and deletions to tumour-specific antigen analyses. – Lytt til Indel derived tumour-specific neoantigens: The Lancet Oncology: Aug 2017 fra Listen to The Lancet Oncology direkte på mobilen din, surfetavlen eller nettleseren - ingen nedlastinger nødvendig. Journal of Oncology publishes research related to breast cancer, lung cancer, gastrointestinal cancer, skin cancer, head and neck cancer, paediatric oncology, neurooncology as well as genitourinary cancer. This is supported by the Lancet Oncology Commission's 2018 discussion about the need to complete the integration of palliative care and oncology in order to promote patientcentered care, improve Chi-Med Highlights Surufatinib Phase III Results in Neuroendocrine Tumors at ESMO 2020 and Publications in The Lancet Oncology PRESS RELEASE GlobeNewswire Sep. 20, 2020, 02:25 PM The study published recently in the prestigious the Lancet Oncology journal has predicted that from 2018 to 2040, the number of patients needing chemotherapy each year will rise by a 53 per cent 3, The Lancet Oncology, journal, 15.650 Q1, 305, 618, 1958, 8994, 18292, 540, 31.00, 14.55, GB. 4, Cancer Cell, journal, 11.909 Q1, 316, 158, 581, 7507 Lancet Oncol.
2. The Lancet Oncology, 183, 300. 3. Clinical Cancer Research, 133, 177. 4. Teng MW, Mok TS, Soo RA (December 2017).